Disc Medicine IRON EPS surprise of 78 lifts shares 108 despite challenges AXGN Axogen Inc posts 202 percent year over year revenue growth in Q4 2025 shares edge higher even as EPS misses estimates The key trends fueling Ur Energy URG growth potential Underperforming 20260507 Brenmiller BNRG Stock Near Breakout Investors Pile In 20260415 How Exagen XGN returns capital to shareholders Q4 2025 Earnings Fall Short The valuation case for Processa Pharmaceuticals PCSA that is hard to ignore 436 20260508 The edge POMDOCTOR POM has in a competitive landscape In Focus 20260506 IPGP IPG posts sharp Q4 2025 earnings beat shares climb 5 percent on strong investor sentiment